Kingsmede is an investment company that owns and manages warehouses, offices, self-storage, residential land and hotels.
Our deep collective knowledge allows us to provide best in class partnership with like minded individual seeking long term value and returns.
We believe no one will care about our properties and tenants to the same level as we do, so every detail is thoroughly discussed and decided in-house, engaging with external consultants when the expertise does not already exist inside the business.
Generate wealth by intimately understanding & exceeding our partner’s expectations, delivering consistent real long-term return & appreciation in real estate assets value.
Acquire assets that will hold value and generate income through the cycles, building on our 30 years of experience in the real estate market to see through trends and identify the genuine needs of real estate users, creating long term sustainable value.
Kingsmede specialises in the acquisition and management of offices, warehouses and residential land. For over thirty years we have created and safeguarded wealth by fanatical attention to detail, to ensure sustainable secure income.
We are centred on long-term ownership with a focus on capital preservation and consistent income returns. To increase value, you must preserve wealth.
With our dedicated team of experts, we ensure that our customers receive the highest level of care and attention.
From maintenance and repairs to tenant relations and financial management, we handle every aspect of property and building management with utmost professionalism and expertise.
At every step, we prioritise customer satisfaction, making sure that our clients can trust us to go above and beyond to meet their expectations.
David, 50 Berry Street
Our most valuable asset is our reputation that has been built & maintained by our team.
At Kingsmede, our foundation is built on the talent, dedication, and diverse expertise of our people. Our team, comprising seasoned professionals, is passionate about delivering exceptional service and results. Their individual journeys, values, and experiences converge to forge Kingsmede’s unique identity, ensuring we remain at the forefront of the industry.
Exceeding expectations
Tailored solutions
Honest communication
Scalable offerings
At Kingsmede, we are deeply invested in making a positive impact on the community and environment. As we grow, we remain dedicated to causes that reflect our values, forging partnerships that drive change and contribute to a brighter, sustainable future.

Kingsmede have partnered with the Foundation for National Parks & Wildlife, to improve our environment by planting native trees in bushfire affected areas.
Our tenants are helping us to aid the restoration of Australia’s native and unique landscape in the years to come. For every new space leased we pledge to plant one tree per employee.
This provides funding to FNPW to plant seedlings in bushfire recovery nurseries, with the goal to plant one million trees across Australia by 2025.

Kingsmede has proudly supported research at the Kolling Institute, contributing to the renal research team’s overarching goal of improving outcomes for patients with chronic kidney disease.
The Institute brings together a highly skilled, multidisciplinary team focused on diagnosing, preventing and treating kidney disease, while improving the standard of care delivered to the community.
Research supported by Kingsmede has helped advance early-stage therapies and has now attracted $1.2M in funding from AstraZeneca, demonstrating how early support can translate into meaningful scientific and commercial impact.
THE SILENT KILLER
OUR AIM
HOW?
THE RESEARCH PROJECT
LATEST ADVANCEMENT: HUMANISED GENETIC RESEARCH MODEL
Researchers have developed an advanced pre-clinical model by inserting a small segment of human DNA into a mouse after removing the corresponding mouse gene. This enables scientists to study how potential drugs interact with human-specific genetic pathways in a controlled environment.
This work is supporting the development of new therapies aimed at improving kidney function, protecting heart health, and enhancing insulin sensitivity in patients with diabetes — accelerating the pathway toward safer and more effective treatments.
Click here for details on how you can help or find out if you are at risk.
*Direct costs $9.9Bn, Indirect costs $13Bn.


Complete the form below to enquire now, or reach out: 0499 157 521

